Full-Time

Quality Specialist II

Confirmed live in the last 24 hours

Freenome

Freenome

201-500 employees

Biotechnology company for early cancer detection

Biotechnology
Healthcare

Compensation Overview

$81.2k - $123.5kAnnually

+ Pre-IPO Equity + Cash Bonuses

Mid

Daly City, CA, USA

This role will be onsite at the Brisbane, California headquarters.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • BS/BA in a life science, engineering, or equivalent discipline; a combination of education and experience will be considered
  • 3+ years of QA experience in an FDA regulated industry, preferably Medical Device or IVD
  • Ability to work effectively in a collaborative team environment
  • Ability to adapt to changing priorities, manage multiple competing priorities with aggressive timelines within a fast-paced environment
  • Attention to detail and commitment to Quality at every stage of the product life cycle
  • Self-driven, ability to work under minimal supervision
  • Excellent written and verbal communication
  • Critical and analytical thinking, ability to assess risks and benefits, and develop effective solutions
Responsibilities
  • Review batch records and Device History Records to ensure completeness and compliance, and disposition product accordingly
  • Collaborate with QC and other functional areas to resolve errors and document nonconformities
  • Author and revise SOPs
  • Participate in regulatory inspections/audits and support inspection readiness activities
  • Assist in performing internal audits and supplier audits
  • Support the Nonconformance and CAPA systems including reviewing, processing, and approving records
  • Assist in root cause investigations
  • Work with QA management to develop KPIs and support the management review process
  • Support QMS improvement and implementation activities
Desired Qualifications
  • Quality Certifications (e.g., CQA, Six Sigma, ISO 13485 Lead Auditor, etc.)
  • Experience using electronic Quality Management Systems

Freenome focuses on improving cancer detection through advanced blood tests. The company uses a multiomics approach, analyzing various biological data types, including genomics and proteomics, to find cancer markers in blood samples. This method allows for non-invasive early detection of cancer, which is crucial for effective treatment. Freenome differentiates itself from competitors by its unique combination of data analysis techniques and its commitment to clinical trials and research collaborations, which enhance the reliability of its tests. The goal of Freenome is to provide healthcare providers and research institutions with accurate diagnostic tools that can lead to earlier cancer detection, ultimately improving patient outcomes.

Company Stage

Late Stage VC

Total Funding

$1B

Headquarters

San Francisco, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

2%

2 year growth

2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent $254 million funding boosts clinical programs and platform expansion.
  • Partnership with Walgreens enhances clinical trial diversity and patient recruitment.
  • PROACT LUNG study positions Freenome as a leader in lung cancer diagnostics.

What critics are saying

  • Employee layoffs may affect morale and innovation efforts.
  • Integration of Oncimmune Ltd. could divert focus from core projects.
  • Competitive landscape in cancer detection may impact Freenome's market share.

What makes Freenome unique

  • Freenome uses a unique multiomics approach for early cancer detection.
  • The company focuses on non-invasive blood tests for cancer screening.
  • Freenome's platform designs personalized health conditions based on cell-free genome analysis.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive market-based salaries

Annual bonus opportunities

Relocation packages

Medical, dental, & vision coverage

401k

Wellness programs

Equity

PTO